tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

QURE Earnings this Week: How Will it Perform?
Pre-EarningsQURE Earnings this Week: How Will it Perform?
16h ago
QURE
Short Report: Quantum Computing bears add exposure into selloff
PremiumThe Fly
Short Report: Quantum Computing bears add exposure into selloff
15d ago
CAKE
PLAY
uniQure’s AMT-130: Promising Huntington’s Disease Therapy with Strong Clinical Efficacy and Favorable Safety Profile
PremiumRatings
uniQure’s AMT-130: Promising Huntington’s Disease Therapy with Strong Clinical Efficacy and Favorable Safety Profile
22d ago
QURE
uniQure price target raised to $110 from $70 at H.C. Wainwright
PremiumThe Fly
uniQure price target raised to $110 from $70 at H.C. Wainwright
22d ago
QURE
uniQure price target raised to $80 from $65 at Wells Fargo
PremiumThe Fly
uniQure price target raised to $80 from $65 at Wells Fargo
26d ago
QURE
Unusually active option classes on open September 26th
PremiumThe FlyUnusually active option classes on open September 26th
1M ago
BA
GDS
uniQure 5.8M share Secondary priced at $47.50
Premium
The Fly
uniQure 5.8M share Secondary priced at $47.50
1M ago
QURE
uniQure price target raised to $80 from $47 at Cantor Fitzgerald
Premium
The Fly
uniQure price target raised to $80 from $47 at Cantor Fitzgerald
1M ago
QURE
uniQure price target raised to $95 from $28 at Guggenheim
PremiumThe Fly
uniQure price target raised to $95 from $28 at Guggenheim
1M ago
QURE
uniQure price target raised to $60 from $30 at Mizuho
PremiumThe Fly
uniQure price target raised to $60 from $30 at Mizuho
1M ago
QURE
uniQure price target raised to $65 from $30 at Wells Fargo
PremiumThe Fly
uniQure price target raised to $65 from $30 at Wells Fargo
1M ago
QURE
uniQure Announces Positive Results for Huntington’s Study
PremiumCompany Announcements
uniQure Announces Positive Results for Huntington’s Study
1M ago
8K
QURE
uniQure Secures $175 Million Loan Amendment
PremiumCompany AnnouncementsuniQure Secures $175 Million Loan Amendment
1M ago
8K
QURE
uniQure’s Promising Advancements in Huntington’s Disease Treatment and Strong Financial Position Justify Buy Rating
Premium
Ratings
uniQure’s Promising Advancements in Huntington’s Disease Treatment and Strong Financial Position Justify Buy Rating
1M ago
QURE
uniQure announces $200M ordinary shares offering
Premium
The Fly
uniQure announces $200M ordinary shares offering
1M ago
QURE
uniQure price target raised to $55 from $24 at RBC Capital
PremiumThe Fly
uniQure price target raised to $55 from $24 at RBC Capital
1M ago
QURE
uniQure price target raised to $68 from $48 at Leerink
PremiumThe Fly
uniQure price target raised to $68 from $48 at Leerink
1M ago
QURE
Micron reports Q4 beat, Instagram reports 3B MAUs: Morning Buzz
PremiumThe Fly
Micron reports Q4 beat, Instagram reports 3B MAUs: Morning Buzz
1M ago
BE
GM
uniQure price target raised to $65 from $30 at Stifel
PremiumThe Fly
uniQure price target raised to $65 from $30 at Stifel
1M ago
QURE
uniQure’s AMT-130 Gene Therapy Shows Promising Results in Huntington’s Disease Trials, Justifying Buy Rating and $70 Price Target
PremiumRatingsuniQure’s AMT-130 Gene Therapy Shows Promising Results in Huntington’s Disease Trials, Justifying Buy Rating and $70 Price Target
1M ago
QURE
uniQure has leading candidate in Huntington’s, says H.C. Wainwright
Premium
The Fly
uniQure has leading candidate in Huntington’s, says H.C. Wainwright
1M ago
QURE
Leerink says uniQure stock could trade up 100% on HD study data
Premium
The Fly
Leerink says uniQure stock could trade up 100% on HD study data
1M ago
QURE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >